FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula I , wherein R2 means methyl, Y means carbon or nitrogen, and R1, R3 and R4 have the value specified in the patent claim. Also, the invention refers to a pharmaceutical composition for the use as a pharmaceutical drug having activity of a phosphatidylinositol-3-kinase inhibitor, to the use of the compounds of formula I for preparing the pharmaceutical drug for treating a disease mediated by phosphatidylinositol 3-kinase and to a method for preparing the compounds of formula I .
EFFECT: preparing the compounds of formula I possessing activity of the phosphatidylinositol-3-kinase inhibitor.
10 cl, 5 tbl, 51 ex
Title | Year | Author | Number |
---|---|---|---|
PURINE DERIVATIVES FOR APPLICATION AS AGONISTS OF ADENOSINE RECEPTOR A-2A | 2005 |
|
RU2403253C2 |
DERIVATIVES OF AZETHIDINE AS ANTAGONISTS OF CCR-3 RECEPTOR | 2003 |
|
RU2314292C2 |
5-PHENYLTIAZOL DERIVATIVES AND THEIR APPLICATION IN CAPACITY OF P13 KINASE INHIBITORS | 2003 |
|
RU2378263C2 |
IMIDAZO(OR TRIAZOLO)PYRIMIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL AGENT INHIBITING SYK TYROSINE KINASE ACTIVITY | 2001 |
|
RU2306313C2 |
PURINE DERIVATIVES AS A RECEPTOR AGONISTS | 2006 |
|
RU2400483C2 |
DERIVATIVES OF PYRAZIOLE WITH CONDENSED CYCLE | 2002 |
|
RU2318822C2 |
INSECTICIDE ANTHRANYLAMIDES | 2001 |
|
RU2278852C2 |
PURINE DERIVATIVES AS INHIBITORS OF TYROSINE PROTEINASE SYK | 2000 |
|
RU2248977C2 |
COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE | 2006 |
|
RU2419610C2 |
THIOLSULFONAMIDE INHIBITORS OF METALLOPROTEASE | 1997 |
|
RU2202540C2 |
Authors
Dates
2013-05-10—Published
2004-04-30—Filed